FindTrial
Sign In

Ovitrelle 250 micrograms solution for injection in pre-filled pen

DRUG5 trials

Sponsors

Ferring Pharmaceuticals A/S, Santiago Dexeus Font Fundacio Privada, Institut De Cancerologie De L Ouest, Centre Hospitalier Intercommunal Creteil, Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA

Conditions

Breast cancerInfertilityInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleWomen with infertility and low ovarian reserve.infertility

Phase 2

Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer (PRESAGE)
RecruitingCTIS2024-516282-37-00
Institut De Cancerologie De L OuestBreast cancer
Start: 2025-02-18Target: 100Updated: 2024-08-09
Using a fixed dosage of follitropin delta for ovarian stimulation for intrauterine insemination. Rekovelle for Intrauterine Successful Experience (RISE )
RecruitingCTIS2025-520681-22-00
Centre Hospitalier Intercommunal CreteilInfertility
Start: 2025-12-17Target: 80Updated: 2025-07-31

Phase 3

A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response after controlled ovarian stimulation with mixed protocols of follitropin delta (REKOVELLE) and highly purified human menopausal gonadotropin (MENOPUR) in women undergoing an assisted reproductive technology programme
Not yet recruitingCTIS2022-500308-23-00
Ferring Pharmaceuticals A/SInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle
Target: 115Updated: 2022-11-09

Phase 4

PErsonalized Addition of Recombinant LH in suboptimal responders >35 years old (POSEIDON group 2). A randomized controlled trial
Not yet recruitingCTIS2024-514035-19-00
Santiago Dexeus Font Fundacio Privadainfertility
Target: 120Updated: 2024-09-23
Phase IV randomized, single-blind clinical trial with three parallel arms to compare ovulation triggering strategies in IVF cycles with fresh embryo transfer.
RecruitingCTIS2026-526292-37-01
Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVAWomen with infertility and low ovarian reserve.
Target: 126Updated: 2026-07-13